Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	KRAB	ZNF705A ZNF311 ZNF211 ZNF562 ZNF705D ZNF705G ZNF19 ZNF836 ZNF41 ZNF728 ZNF432 ZNF552 ZNF701 ZNF705B	1.92e-08	358	108	14	PS50805
Domain	KRAB	ZNF705A ZNF311 ZNF211 ZNF562 ZNF705D ZNF705G ZNF19 ZNF836 ZNF41 ZNF728 ZNF432 ZNF552 ZNF701 ZNF705B	1.92e-08	358	108	14	PF01352
Domain	KRAB	ZNF705A ZNF311 ZNF211 ZNF562 ZNF705D ZNF705G ZNF19 ZNF836 ZNF41 ZNF728 ZNF432 ZNF552 ZNF701 ZNF705B	2.81e-08	369	108	14	SM00349
Domain	KRAB	ZNF705A ZNF311 ZNF211 ZNF562 ZNF705D ZNF705G ZNF19 ZNF836 ZNF41 ZNF728 ZNF432 ZNF552 ZNF701 ZNF705B	2.91e-08	370	108	14	IPR001909
Domain	-	ZNF705A ZNF311 ZNF211 ZNF562 MYNN ZNF705D ZNF705G ZNF19 ZNF836 ZNF41 ZNF728 ZNF432 ZNF552 ZNF701 ZNF705B ZNF107	1.77e-06	679	108	16	3.30.160.60
Domain	ZINC_FINGER_C2H2_2	ZNF705A ZNF311 ZNF211 ZNF562 MYNN ZNF705D ZNF705G ZNF106 ZNF19 ZNF836 ZNF41 ZNF728 ZNF432 ZNF552 ZNF701 ZNF705B ZNF107	2.15e-06	775	108	17	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF705A ZNF311 ZNF211 ZNF562 MYNN ZNF705D ZNF705G ZNF106 ZNF19 ZNF836 ZNF41 ZNF728 ZNF432 ZNF552 ZNF701 ZNF705B ZNF107	2.23e-06	777	108	17	PS00028
Domain	zf-C2H2	ZNF705A ZNF311 ZNF211 ZNF562 MYNN ZNF705D ZNF106 ZNF19 ZNF836 ZNF41 ZNF728 ZNF432 ZNF552 ZNF701 ZNF705B ZNF107	2.30e-06	693	108	16	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	ZNF705A ZNF311 ZNF211 ZNF562 MYNN ZNF705D ZNF705G ZNF19 ZNF836 ZNF41 ZNF728 ZNF432 ZNF552 ZNF701 ZNF705B ZNF107	2.35e-06	694	108	16	IPR013087
Domain	Znf_C2H2-like	ZNF705A ZNF311 ZNF211 ZNF562 MYNN ZNF705D ZNF705G ZNF106 ZNF19 ZNF836 ZNF41 ZNF728 ZNF432 ZNF552 ZNF701 ZNF705B ZNF107	3.08e-06	796	108	17	IPR015880
Domain	Znf_C2H2	ZNF705A ZNF311 ZNF211 ZNF562 MYNN ZNF705D ZNF705G ZNF106 ZNF19 ZNF836 ZNF41 ZNF728 ZNF432 ZNF552 ZNF701 ZNF705B ZNF107	3.58e-06	805	108	17	IPR007087
Domain	ZnF_C2H2	ZNF705A ZNF311 ZNF211 ZNF562 MYNN ZNF705D ZNF705G ZNF106 ZNF19 ZNF836 ZNF41 ZNF728 ZNF432 ZNF552 ZNF701 ZNF705B ZNF107	3.77e-06	808	108	17	SM00355
Domain	zf-C2H2_6	ZNF311 ZNF211 ZNF562 MYNN ZNF836 ZNF728 ZNF432 ZNF701 ZNF107	8.71e-05	314	108	9	PF13912
Domain	Myosin_head_motor_dom	MYO9A MYO9B MYO1B	1.37e-03	38	108	3	IPR001609
Domain	MYOSIN_MOTOR	MYO9A MYO9B MYO1B	1.37e-03	38	108	3	PS51456
Domain	Myosin_head	MYO9A MYO9B MYO1B	1.37e-03	38	108	3	PF00063
Domain	MYSc	MYO9A MYO9B MYO1B	1.37e-03	38	108	3	SM00242
Domain	PNMA	ZCCHC18 ZCCHC12	1.76e-03	11	108	2	PF14893
Domain	PNMA	ZCCHC18 ZCCHC12	1.76e-03	11	108	2	IPR026523
Domain	Helicase_C	CHD8 DHX8 POLQ HELLS	3.46e-03	107	108	4	PF00271
Domain	HELICc	CHD8 DHX8 POLQ HELLS	3.46e-03	107	108	4	SM00490
Domain	Helicase_C	CHD8 DHX8 POLQ HELLS	3.57e-03	108	108	4	IPR001650
Domain	HELICASE_CTER	CHD8 DHX8 POLQ HELLS	3.69e-03	109	108	4	PS51194
Domain	HELICASE_ATP_BIND_1	CHD8 DHX8 POLQ HELLS	3.69e-03	109	108	4	PS51192
Domain	DEXDc	CHD8 DHX8 POLQ HELLS	3.69e-03	109	108	4	SM00487
Domain	Helicase_ATP-bd	CHD8 DHX8 POLQ HELLS	3.82e-03	110	108	4	IPR014001
Pubmed	Acetylation-Mimic Mutation of TRIM28-Lys304 to Gln Attenuates the Interaction with KRAB-Zinc-Finger Proteins and Affects Gene Expression in Leukemic K562 Cells.	ZNF311 ZNF211 ZNF562 RANBP9 ZNF41 ZNF728 ZNF432 ZNF552 ZNF701 ZNF107	4.44e-10	181	113	10	37372979
Pubmed	A human MAP kinase interactome.	RANBP2 MYO9A CCDC186 RANBP9 CHD8 MYNN ZNF106 SYNJ2 NAV2 CPLANE1 NUP153	5.73e-07	486	113	11	20936779
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	RANBP2 ANK2 MYO9A RPN2 HLCS MYO1B ARFGAP1 NCAPD2 CTTN CNOT1 NUP153 VCL	3.50e-06	708	113	12	39231216
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RANBP2 ANK2 ARMC3 RPN2 KRT74 MYO1B MYNN C6orf118 STS PWP2 NCAPD2 SYCP1 NAV2 USPL1 CTTN POLQ RPL3L	4.21e-06	1442	113	17	35575683
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	PCNP RANBP2 UBAP2 RPN2 ATAD5 DHX8 SPATS2L SYNJ2 CTTN CNOT1 VCL HELLS	4.40e-06	724	113	12	36232890
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	RANBP2 RPN2 MYO1B CHD8 DHX8 PWP2 NCAPD2 PUM3 CNOT1 NUP153 VCL	9.68e-06	653	113	11	22586326
Pubmed	Identification of proteins that interact with murine cytomegalovirus early protein M112-113 in brain.	ZCCHC18 ZCCHC12	1.05e-05	2	113	2	22340173
Pubmed	Polymorphisms of protein tyrosine phosphatase CD148 influence FcγRIIA-dependent platelet activation and the risk of heparin-induced thrombocytopenia.	PTPRJ FCGR2A	1.05e-05	2	113	2	22677127
Pubmed	Knockdown screens to knockout HIV-1.	RANBP2 NUP153	1.05e-05	2	113	2	18984154
Pubmed	The Microtubule Plus End Tracking Protein TIP150 Interacts with Cortactin to Steer Directional Cell Migration.	CTTN MTUS2	1.05e-05	2	113	2	27451391
Pubmed	Class IX Myosins: Motorized RhoGAP Signaling Molecules.	MYO9A MYO9B	1.05e-05	2	113	2	32451867
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	TNIK PCNP RANBP2 UBAP2 ANK2 ATAD5 HLCS MYO1B ARFGAP1 CTTN NUP153 VCL HELLS	1.12e-05	934	113	13	33916271
Pubmed	Identification and overlapping expression of multiple unconventional myosin genes in vertebrate cell types.	MYO9A MYO9B MYO1B	1.18e-05	14	113	3	8022818
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	RANBP2 UBAP2 LRCH2 CHD8 PWP2 SGO2 PUM3 CTTN NUP153	1.43e-05	440	113	9	34244565
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	TNIK RANBP2 LRCH2 VPS13C HLCS BRCA2 SYNJ2 ARFGAP1 CTTN CPLANE1 CNOT1 VCL	2.25e-05	853	113	12	28718761
Pubmed	An αIIb β3 antagonist prevents thrombosis without causing Fc receptor γ-chain IIa-mediated thrombocytopenia.	ITGA2B FCGR2A	3.13e-05	3	113	2	28815933
Pubmed	What is vinculin needed for in platelets?	ITGA2B VCL	3.13e-05	3	113	2	20670372
Pubmed	Heterogeneous susceptibility of circulating SIV isolate capsids to HIV-interacting factors.	RANBP2 NUP153	3.13e-05	3	113	2	23883001
Pubmed	Toll-like receptor 2 ligands regulate monocyte Fcγ receptor expression and function.	FCGR2A TLR2	3.13e-05	3	113	2	23504312
Pubmed	Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors.	SCARF1 TLR2	3.13e-05	3	113	2	15894273
Pubmed	The scavenger receptors SRA-1 and SREC-I cooperate with TLR2 in the recognition of the hepatitis C virus non-structural protein 3 by dendritic cells.	SCARF1 TLR2	3.13e-05	3	113	2	20338659
Pubmed	Impact of surface receptors TLR2, CR3, and FcγRIII on Rhodococcus equi phagocytosis and intracellular survival in macrophages.	FCGR2A TLR2	3.13e-05	3	113	2	38018994
Pubmed	[The role of lung cancer related gene methylation in the early diagnosis of lung cancer].	DAPK1 TLR2	3.13e-05	3	113	2	32867455
Pubmed	Full-sized RanBPM cDNA encodes a protein possessing a long stretch of proline and glutamine within the N-terminal region, comprising a large protein complex.	RANBP2 RANBP9	3.13e-05	3	113	2	11470507
Pubmed	Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets.	ITGA2B FCGR2A	3.13e-05	3	113	2	18641368
Pubmed	Hepatic arginase 2 (Arg2) is sufficient to convey the therapeutic metabolic effects of fasting.	LEPR RGS16	3.13e-05	3	113	2	30962478
Pubmed	Toll like receptor 2/1 mediated platelet adhesion and activation on bacterial mimetic surfaces is dependent on src/Syk-signaling and purinergic receptor P2X1 and P2Y12 activation.	FCGR2A TLR2	3.13e-05	3	113	2	25553878
Pubmed	A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells.	PCNP RANBP2 CHD8 CTTN NUP153	4.88e-05	121	113	5	22412018
Pubmed	Pyramidal neurons form active, transient, multilayered circuits perturbed by autism-associated mutations at the inception of neocortex.	ZCCHC18 ZCCHC12 CHD8	5.64e-05	23	113	3	37071993
Pubmed	HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency.	RANBP2 NUP153	6.25e-05	4	113	2	22174692
Pubmed	Murine macrophage TLR2-FcγR synergy via FcγR licensing of IL-6 cytokine mRNA ribosome binding and translation.	FCGR2A TLR2	6.25e-05	4	113	2	30024985
Pubmed	BIG1 is a binding partner of myosin IXb and regulates its Rho-GTPase activating protein activity.	MYO9A MYO9B	6.25e-05	4	113	2	15644318
Pubmed	Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis.	HSD17B7 STS	6.25e-05	4	113	2	17454161
Pubmed	Clinical relevance of TLR2, TLR4, CD14 and FcgammaRIIA gene polymorphisms in Streptococcus pneumoniae infection.	FCGR2A TLR2	6.25e-05	4	113	2	18180796
Pubmed	Alpha5beta1, alphaVbeta3 and the platelet-associated integrin alphaIIbbeta3 coordinately regulate adhesion and migration of differentiating mouse trophoblast cells.	ITGA2B VCL	6.25e-05	4	113	2	15031111
Pubmed	Molecular mechanisms of retroviral integration site selection.	RANBP2 NUP153	6.25e-05	4	113	2	25147212
Pubmed	Blood-stage malaria parasites manipulate host innate immune responses through the induction of sFGL2.	FCGR2A TLR2	6.25e-05	4	113	2	32133407
Pubmed	Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma.	DAPK1 CHFR	6.25e-05	4	113	2	21302620
Pubmed	Reduced c-Myb activity compromises HSCs and leads to a myeloproliferation with a novel stem cell basis.	ITGA2B FCGR2A	6.25e-05	4	113	2	19360001
Pubmed	Human ZCCHC12 activates AP-1 and CREB signaling as a transcriptional co-activator.	ZCCHC18 ZCCHC12	6.25e-05	4	113	2	19578717
Pubmed	Tpr is localized within the nuclear basket of the pore complex and has a role in nuclear protein export.	RANBP2 NUP153	6.25e-05	4	113	2	11839768
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	RANBP2 UBAP2 ATAD5 CHD8 ZDBF2 BRCA2 PWP2 SGO2 PUM3 CTTN NUP153 HELLS	6.61e-05	954	113	12	36373674
Pubmed	Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach.	RANBP2 MYO9A RPN2 MYO9B NUP153 HELLS	6.84e-05	211	113	6	17314511
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TNIK RANBP2 UBAP2 LRCH2 ANK2 RANBP9 DAPK1 CHD8 LZTS1 CTTN CNOT1 NUP153	7.23e-05	963	113	12	28671696
Pubmed	Genome-wide association study of exercise behavior in Dutch and American adults.	LEPR SPATS2L	1.04e-04	5	113	2	19727025
Pubmed	RanGTP mediates nuclear pore complex assembly.	RANBP2 NUP153	1.04e-04	5	113	2	12894213
Pubmed	The N-terminal domain of the mammalian nucleoporin p62 interacts with other nucleoporins of the FXFG family during interphase.	RANBP2 NUP153	1.04e-04	5	113	2	16730000
Pubmed	Steady-state nuclear localization of exportin-t involves RanGTP binding and two distinct nuclear pore complex interaction domains.	RANBP2 NUP153	1.04e-04	5	113	2	12138183
Pubmed	Dynamic localization of SMC5/6 complex proteins during mammalian meiosis and mitosis suggests functions in distinct chromosome processes.	SYCP1 SGO2	1.04e-04	5	113	2	23843628
Pubmed	HIV-1 Resistance to the Capsid-Targeting Inhibitor PF74 Results in Altered Dependence on Host Factors Required for Virus Nuclear Entry.	RANBP2 NUP153	1.04e-04	5	113	2	26109731
Pubmed	A giant nucleopore protein that binds Ran/TC4.	RANBP2 NUP153	1.04e-04	5	113	2	7603572
Pubmed	A model for cofactor use during HIV-1 reverse transcription and nuclear entry.	RANBP2 NUP153	1.04e-04	5	113	2	24525292
Pubmed	Src-dependent phosphorylation of ASAP1 regulates podosomes.	CTTN VCL	1.04e-04	5	113	2	17893324
Pubmed	Regulation of Tat acetylation and transactivation activity by the microtubule-associated deacetylase HDAC6.	HTATIP2 CTTN	1.04e-04	5	113	2	21220424
Pubmed	Sizn1 is a novel protein that functions as a transcriptional coactivator of bone morphogenic protein signaling.	ZCCHC18 ZCCHC12	1.04e-04	5	113	2	18160706
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	TNIK CACNA1F ZNF311 ANK2 LEPR BRCA2 SYNJ2	1.04e-04	329	113	7	17474147
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	PCNP RANBP2 CHD8 ZNF106 BRCA2 ARFGAP1 CTTN HELLS	1.05e-04	444	113	8	34795231
Pubmed	ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.	ZNF311 RPN2 RANBP9 ZNF836 ZNF701 CTTN ZNF107 VCL	1.17e-04	451	113	8	36168627
Pubmed	PINCH2 is a new five LIM domain protein, homologous to PINCHand localized to focal adhesions.	ITGA2B VCL	1.56e-04	6	113	2	12651156
Pubmed	XLMR candidate mouse gene, Zcchc12 (Sizn1) is a novel marker of Cajal-Retzius cells.	ZCCHC18 ZCCHC12	1.56e-04	6	113	2	21172456
Pubmed	The gene encoding disabled-1 (DAB1), the intracellular adaptor of the Reelin pathway, reveals unusual complexity in human and mouse.	LEPR C8B	1.56e-04	6	113	2	12446734
Pubmed	Gradient of increasing affinity of importin beta for nucleoporins along the pathway of nuclear import.	RANBP2 NUP153	1.56e-04	6	113	2	11266456
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	PCNP RANBP2 UBAP2 ZDBF2 ARFGAP1 CTTN	1.96e-04	256	113	6	33397691
Pubmed	SUMO interaction motifs in Sizn1 are required for promyelocytic leukemia protein nuclear body localization and for transcriptional activation.	ZCCHC18 ZCCHC12	2.17e-04	7	113	2	19416967
Pubmed	CDCA7-associated global aberrant DNA hypomethylation translates to localized, tissue-specific transcriptional responses.	VCL HELLS	2.17e-04	7	113	2	38335290
Pubmed	New insights in the role of nucleoporins: a bridge leading to concerted steps from HIV-1 nuclear entry until integration.	RANBP2 NUP153	2.17e-04	7	113	2	24051001
Pubmed	Meiosis-Specific C19orf57/4930432K21Rik/BRME1 Modulates Localization of RAD51 and DMC1 to DSBs in Mouse Meiotic Recombination.	BRCA2 SYCP1	2.17e-04	7	113	2	32460033
Pubmed	Tails of unconventional myosins.	MYO9A MYO9B	2.17e-04	7	113	2	11212352
Pubmed	Zeb2 is a negative regulator of midbrain dopaminergic axon growth and target innervation.	ZCCHC18 ZCCHC12	2.17e-04	7	113	2	28819210
Pubmed	Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex.	RANBP2 NUP153	2.17e-04	7	113	2	12192048
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	RANBP2 RPN2 VPS13C MYO1B DHX8 PWP2 NCAPD2 SGO2 PUM3 CTTN CNOT1 NUP153 VCL HELLS	2.19e-04	1425	113	14	30948266
Pubmed	Human transcription factor protein interaction networks.	UBAP2 RPN2 ATAD5 KRT74 MYO1B CHD8 FAT1 ARFGAP1 PUM3 CTTN ZNF107 CNOT1 VCL HELLS	2.26e-04	1429	113	14	35140242
Pubmed	UM171 Preserves Epigenetic Marks that Are Reduced in Ex Vivo Culture of Human HSCs via Potentiation of the CLR3-KBTBD4 Complex.	RANBP2 UBAP2 ANK2 ARFGAP1 NCAPD2 CTTN	2.46e-04	267	113	6	33417871
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	RANBP2 RANBP9 MYO1B ZDBF2 PWP2 HELLS	2.72e-04	272	113	6	31010829
Pubmed	Common genetic variants in the interleukin-6 and chitotriosidase genes are associated with the risk for serious infection in children undergoing therapy for acute myeloid leukemia.	FCGR2A TLR2	2.89e-04	8	113	2	16107886
Pubmed	Roles of HIV-1 capsid in viral replication and immune evasion.	RANBP2 NUP153	2.89e-04	8	113	2	25036886
Pubmed	Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE.	FCGR2A TLR2	2.89e-04	8	113	2	17417641
Pubmed	The transient appearance of zipper-like actin superstructures during the fusion of osteoclasts.	CTTN VCL	2.89e-04	8	113	2	22349694
Pubmed	Targeting UBE4A Revives Viperin Protein in Epithelium to Enhance Host Antiviral Defense.	RANBP2 RPN2	2.89e-04	8	113	2	31812350
Pubmed	Microdissection and microcloning of mid-chromosome 4: genetic mapping of 41 microdissection clones.	LEPR C8B	2.89e-04	8	113	2	8098006
Pubmed	Imaging within single NPCs reveals NXF1's role in mRNA export on the cytoplasmic side of the pore.	RANBP2 NUP153	2.89e-04	8	113	2	31375530
Pubmed	SPOCD1 is an essential executor of piRNA-directed de novo DNA methylation.	PIWIL4 SYCP1	2.89e-04	8	113	2	32674113
Pubmed	USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities.	ZCCHC18 ZCCHC12 LRCH2 NXT2 BCLAF3 SCARF1 FCGR2A TLR2 NAV2	3.65e-04	674	113	9	37196079
Pubmed	Cloning and characterization of human karyopherin beta3.	RANBP2 NUP153	3.71e-04	9	113	2	9114010
Pubmed	TBR1 regulates autism risk genes in the developing neocortex.	ANK2 CHD8	3.71e-04	9	113	2	27325115
Pubmed	PRDM9 interactions with other proteins provide a link between recombination hotspots and the chromosomal axis in meiosis.	SYCP1 CDYL	3.71e-04	9	113	2	27932493
Pubmed	Mammalian Fat1 cadherin regulates actin dynamics and cell-cell contact.	FAT1 VCL	3.71e-04	9	113	2	15148305
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	RANBP2 HSD17B7 DCAF8 BCLAF3 ZNF106 SYNJ2 SYCP1 ZNF552 SGO2 CNOT1 NUP153 VCL	3.86e-04	1155	113	12	20360068
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	PCNP UBAP2 CHD8 ARFGAP1 NCAPD2 CTTN CNOT1 VCL	4.40e-04	549	113	8	38280479
Pubmed	In vitro nuclear interactome of the HIV-1 Tat protein.	RANBP2 CHD8 NCAPD2 PUM3 NUP153	4.53e-04	195	113	5	19454010
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	UBAP2 RPN2 MYO9B ALPK1 FAT1 ASXL3 NAV2 CPLANE1	4.56e-04	552	113	8	10737800
Pubmed	TGFβ pathway is required for viable gestation of Fanconi anemia embryos.	ITGA2B VCL	4.63e-04	10	113	2	36441774
Pubmed	MOV10L1 is necessary for protection of spermatocytes against retrotransposons by Piwi-interacting RNAs.	PIWIL4 SYCP1	4.63e-04	10	113	2	20547853
Pubmed	Characterization of the epithelial membrane protein 3 interaction network reveals a potential functional link to mitogenic signal transduction regulation.	HTATIP2 CMTM5	4.63e-04	10	113	2	30614533
Pubmed	Gene expression analysis of the embryonic subplate.	ZCCHC18 ZCCHC12 MYO9A MYO1B SLITRK3	4.63e-04	196	113	5	21862448
Pubmed	Hundreds of variants clustered in genomic loci and biological pathways affect human height.	MYO9A MYO9B ATAD5 ADAMTSL3 PTPRJ	4.85e-04	198	113	5	20881960
Pubmed	Mapping of unconventional myosins in mouse and human.	MYO9A MYO9B MYO1B	5.19e-04	48	113	3	8884266
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	RPN2 MYO9B MYO1B NCAPD2 CNOT1	5.31e-04	202	113	5	33005030
Pubmed	A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition.	ZCCHC18 UBAP2 ASXL3 NCAPD2 CMTM5 CPLANE1 NUP153	5.35e-04	431	113	7	33660365
Pubmed	Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR.	MYNN ZNF836 ZNF107	5.52e-04	49	113	3	9630514
Interaction	MAGEA9 interactions	MYO9A MYO9B ATAD5 ZDBF2 BRCA2 POLQ CNOT1 HELLS	1.75e-05	208	109	8	int:MAGEA9
Interaction	PAPSS2 interactions	PCNP RPN2 DAPK1 SARAF C8B	1.82e-05	60	109	5	int:PAPSS2
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF705A ZNF311 ZNF211 ZNF562 MYNN ZNF705D ZNF705G ZNF106 ZNF19 ZNF836 ZNF41 ZNF728 ZNF432 ZNF552 ZNF701 ZNF705B ZNF107	8.18e-09	718	78	17	28
GeneFamily	Myosins, class IX	MYO9A MYO9B	1.84e-05	2	78	2	1103
GeneFamily	Paraneoplastic Ma antigens	ZCCHC18 ZCCHC12	9.85e-04	11	78	2	671
GeneFamily	Zinc fingers RANBP2-type \|RNA binding motif containing	RANBP2 NUP153	3.66e-03	21	78	2	89
GeneFamily	Short chain dehydrogenase/reductase superfamily	HSD17B7 HTATIP2 DHRS9	4.33e-03	76	78	3	743
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000	PUS3 MYO9A PABPC4L CHD8 NAV2 CPLANE1 NUP153 HELLS	1.74e-05	225	106	8	gudmap_developingGonad_e14.5_ ovary_1000_k3
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000	TNIK MYO9A ATAD5 PABPC4L ZDBF2 ALPK1 FREM1 FAT1 SPATS2L BRCA2 ASXL3 ARFGAP1 NCAPD2 CTTN	2.83e-05	768	106	14	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000
ToppCell	Control-Endothelial-Endothelial-FOXM1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ATAD5 BRCA2 NCAPD2 SYCP1 NAV2 SGO2 POLQ HELLS	2.94e-08	189	113	8	1e1499b062d9c647c8f38b0c4e0d871d159be5dd
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ATAD5 BRCA2 NCAPD2 SGO2 UNC13C POLQ HELLS	5.10e-07	187	113	7	057569c9437219ecc396aa6e673b1178a2273837
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNIK ATAD5 LZTS1 NCAPD2 SYCP1 FGD3	3.05e-06	157	113	6	a633fb8e7a009490c6002bf272eceaf317f27af6
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	4.66e-06	169	113	6	e0607af8ae8609d43e26ff2a2cab92650bfcd5b7
ToppCell	Dividing_Macrophages-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	6.27e-06	178	113	6	1893fadac2ec3d5de0a641e57b7b2f962012a9ba
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	6.68e-06	180	113	6	401df9cddcbca1eb8f0d2687bcacd98e95dc1493
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1F MYO9A DAPK1 MYO1B PLEKHG4B NAV2	6.90e-06	181	113	6	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1F GRID1 FREM1 FAT1 ASXL3 UNC13C	7.58e-06	184	113	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	PABPC4L ADAMTSL3 LEPR FREM1 ZNF106 ZNF728	7.58e-06	184	113	6	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1F GRID1 FREM1 FAT1 ASXL3 UNC13C	7.58e-06	184	113	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1F GRID1 FREM1 FAT1 ASXL3 UNC13C	7.58e-06	184	113	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	COVID-19-Fibroblasts-Pericytes\|COVID-19 / group, cell type (main and fine annotations)	LRCH2 MYO1B GRID1 ADAMTSL3 RGS16 LZTS1	7.82e-06	185	113	6	4905adaeeffd353e089578e5ea614437dbe794e6
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	7.82e-06	185	113	6	30e041d6f6e310d64809e9d6d93cd30052972f3b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	8.31e-06	187	113	6	e41e39fd3791acf8ae5376cc5061e196d96868ae
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	8.31e-06	187	113	6	cefa211ef224e803ea9467882e2ca74d0b1492f1
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	8.31e-06	187	113	6	9351fa87b69a951af85b10bf91fe9b1cce8c0517
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK SPATA6L MYO9A DAPK1 DNAH14 CFAP54	8.57e-06	188	113	6	63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK CEBPD MYO9A DAPK1 LEPR CFAP54	8.83e-06	189	113	6	bd91bdfe35294e60d980259b70fe9e60dca2743f
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	PABPC4L MYO1B FREM1 SPATS2L NAV2 VCL	9.10e-06	190	113	6	1196b8ea2c44c7c80f5ee589dd517e6a413f2077
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SPATA6L MYO9A DAPK1 DNAH14 CFAP54 NAV2	9.10e-06	190	113	6	3fc9e18c7441c0ae8cda65753cc42d0520f4e116
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UBAP2 ATAD5 LZTS1 NCAPD2 SGO2 HELLS	9.10e-06	190	113	6	b99271d139c8d01e20feb95d99f79c9b2756b4cb
ToppCell	pdx-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	9.10e-06	190	113	6	d06ee5f89f1cec8db6897fe3b2a890a07cd3697b
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK SPATA6L DAPK1 FREM1 PTPRJ UNC13C	9.38e-06	191	113	6	3e828cffa24ded19f591a7ed6c1fe88ad57fdcac
ToppCell	3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T\|bone_marrow / Manually curated celltypes from each tissue	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	9.38e-06	191	113	6	210a0f1a71df2508cbfc73d6868a2122338b9a1c
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T\|GI_small-bowel / Manually curated celltypes from each tissue	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	9.38e-06	191	113	6	e642fa7395c05fb53324c9d46bbc52f89fc9673f
ToppCell	RV-08._Macrophage\|World / Chamber and Cluster_Paper	DAPK1 PTPRJ BRCA2 FCGR2A TLR2 FGD3	9.66e-06	192	113	6	a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3
ToppCell	human_hepatoblastoma-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	9.95e-06	193	113	6	4b9fa2a4424f8abe63fa7bee78db93dda04ab15f
ToppCell	3'_v3-Lung-Myeloid_Mac-Cycling_Myeloid-Mac\|Lung / Manually curated celltypes from each tissue	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.02e-05	194	113	6	a8ae49157ca3f9e8b3f1750a995aee012dc859b6
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK SPATA6L DAPK1 FREM1 PTPRJ UNC13C	1.02e-05	194	113	6	04bfc555743f7d8821439d05ae442d15e9886c59
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK SPATA6L DAPK1 FREM1 PTPRJ UNC13C	1.02e-05	194	113	6	69bff17df4a760ccf081cf52ff04af02c14f448d
ToppCell	COVID_vent-Myeloid-Monocytic-Neutrophil\|COVID_vent / Disease condition, Lineage, Cell class and subclass	UPB1 CEBPD ALPK1 FCGR2A TLR2 DHRS9	1.02e-05	194	113	6	eb23b171e429165dd26a64377eae7fa2ce25f547
ToppCell	COVID-19-T_cells-Cycling_NK/T_cells\|COVID-19 / group, cell type (main and fine annotations)	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.06e-05	195	113	6	764ed100c28d9bc93ee5ecabc5291c8f184d78da
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADAMTSL3 ITIH3 FREM1 ZNF106 SPATS2L MTUS2	1.09e-05	196	113	6	308fa54385ca34e9e590967d4553b84aad96c92f
ToppCell	10x5'-lymph-node_spleen-Myeloid_Dendritic-DC2\|lymph-node_spleen / Manually curated celltypes from each tissue	CEBPD DAPK1 SCARF1 SPATS2L FCGR2A TLR2	1.09e-05	196	113	6	9666b5380e2b2a3c3b56a8c769817a1df8820ed6
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SPATA6L ANK2 DAPK1 FAT1 PTPRJ UNC13C	1.09e-05	196	113	6	c7136b1c83bcf907eec3b02b151fa061298b6672
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_cycling\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.09e-05	196	113	6	1d2e0b328eb822db7521b5f5724d4bd17c0bad5f
ToppCell	COVID-19-lung-Pericytes/_Smooth_Muscle\|COVID-19 / Disease (COVID-19 only), tissue and cell type	LRCH2 MYO1B GRID1 ADAMTSL3 RGS16 LZTS1	1.09e-05	196	113	6	754a3613340932563cd8424d775e18b93c3a1aaa
ToppCell	Healthy-T/NK_proliferative\|World / disease group, cell group and cell class	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.12e-05	197	113	6	e90be1e7e02f736b6aab14010a912b592d6f1e80
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_cycling\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.12e-05	197	113	6	8b616cde333bdbc0c591035ad9e4949155866245
ToppCell	distal-mesenchymal-Vascular_Smooth_Muscle-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LRCH2 MYO1B ADAMTSL3 ITIH3 RGS16 LZTS1	1.12e-05	197	113	6	da653dc7d216e202f390e5ab0245f243e3ed213b
ToppCell	COVID-19_Moderate-T/NK_proliferative\|COVID-19_Moderate / disease group, cell group and cell class	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.15e-05	198	113	6	166c000fb0e19602ffdd8bf2b2f19be2c6df96a6
ToppCell	COVID-19_Moderate-T/NK_proliferative\|World / disease group, cell group and cell class	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.15e-05	198	113	6	bf0131fbca6032e1aab4aa807f8c1d3be689cb7f
ToppCell	distal-2-mesenchymal-Vascular_Smooth_Muscle\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LRCH2 MYO1B ADAMTSL3 ITIH3 RGS16 LZTS1	1.15e-05	198	113	6	ce05ede69c167b2294630709bb0c223483a6ef75
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.18e-05	199	113	6	e98ff036d04fc78dffef156bdc0d644532274067
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CACNA1F MYO9A DAPK1 MYO1B NAV2 FGD3	1.18e-05	199	113	6	d43c605a4ff221cf78d91678c15d2ad20f831c7f
ToppCell	10x5'-Lung-Myeloid_Mac-Cycling_Myeloid-Mac\|Lung / Manually curated celltypes from each tissue	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.18e-05	199	113	6	dee1cf8ee850a2bd57349418a9bcc0948fe9ac9e
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.18e-05	199	113	6	4af38f5e9d2229d64f7ecdf9c00b4d67e5f86a51
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.18e-05	199	113	6	7feedb0bf84a3361c8ab5b6674ff64e8ff140c23
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.18e-05	199	113	6	123fbf2122aa221d8cbf3aef9361ba0982c07695
ToppCell	COVID-19_Severe-Lymphoid_T/NK-T/NK_proliferative\|COVID-19_Severe / Disease group, lineage and cell class	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.18e-05	199	113	6	ddae7fe7633661f15d3c79f5187415ffbfecce67
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADAMTSL3 ITIH3 FREM1 ZNF106 SPATS2L MTUS2	1.18e-05	199	113	6	eeb7d370d4dfacf705306c72ccc4919ddefacff1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.18e-05	199	113	6	6b1304417cf9c44ca70d2bfc2b5acc1a206f25b6
ToppCell	Dividing_Macrophages\|World / lung cells shred on cell class, cell subclass, sample id	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.18e-05	199	113	6	5c755b6876e164dc847ef7c723f850f227cf3a87
ToppCell	LPS_IL1RA-Endothelial-Endothelial-FOXM1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ATAD5 BRCA2 NCAPD2 NAV2 POLQ HELLS	1.18e-05	199	113	6	be2276c9a1994579ba1d2998b49bf549c1324d44
ToppCell	distal-Hematologic-Proliferating_Macrophage\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.22e-05	200	113	6	3835a8a9739b8cd5bf19c40765ef76907ac1ad38
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYO1B ADAMTSL3 ITIH3 FAT1 LZTS1 VCL	1.22e-05	200	113	6	b5b5a32925f225610fe25a021a742d6397162863
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell\|2m / Sample Type, Dataset, Time_group, and Cell type.	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.22e-05	200	113	6	0d9b8d51a7630e70e60c76c763ff82df4c559152
ToppCell	Control_saline-Endothelial-Endothelial-FOXM1\|Control_saline / Treatment groups by lineage, cell group, cell type	ATAD5 BRCA2 NCAPD2 NAV2 POLQ HELLS	1.22e-05	200	113	6	9bbc7b5561151f6ff65f40b3226271def732e5d9
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYO1B ADAMTSL3 FAT1 SYNJ2 LZTS1 VCL	1.22e-05	200	113	6	4e1e19214aeebbdca004de7faaf4cc9d18498591
ToppCell	healthy_donor-Lymphocytic-Proliferative_Lymphocyte\|healthy_donor / Disease condition, Lineage, Cell class and subclass	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.22e-05	200	113	6	e4eb915c29909cf8535a3603c68976545c05e54b
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells\|2m / Sample Type, Dataset, Time_group, and Cell type.	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.22e-05	200	113	6	0675f580ccef705875854247bbfd4ee2bcf126a1
ToppCell	healthy_donor-Lymphocytic-Proliferative_Lymphocyte-\|healthy_donor / Disease condition, Lineage, Cell class and subclass	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.22e-05	200	113	6	415e7556b5ac45688e2c6c30a52bd40e0eb27c7d
ToppCell	distal-Hematologic-Proliferating_Macrophage-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ATAD5 BRCA2 SGO2 C8B POLQ HELLS	1.22e-05	200	113	6	9c03a8da12d29618f72c429836c1d1bd84a78b12
ToppCell	Severe-T/NK_proliferative\|Severe / Disease group and Cell class	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.22e-05	200	113	6	4723613a9f56bff422fc98722128d57b6adf3c5d
ToppCell	COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.22e-05	200	113	6	04bf9e6a0fbd792b49eed63dabba5d6fafed8c07
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYO1B ADAMTSL3 FAT1 SYNJ2 LZTS1 VCL	1.22e-05	200	113	6	786f1ae53e60b5ffbf4bfd393d10b802478148b3
ToppCell	Severe-T/NK_proliferative\|World / Disease group and Cell class	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.22e-05	200	113	6	128d82eb4d5760adf872212d8e8b5787a889969f
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte\|Control_saline / Treatment groups by lineage, cell group, cell type	MYO1B ADAMTSL3 ITIH3 FAT1 LZTS1 VCL	1.22e-05	200	113	6	cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c
ToppCell	COVID_vent-Lymphocytic-Proliferative_Lymphocyte-\|COVID_vent / Disease condition, Lineage, Cell class and subclass	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.22e-05	200	113	6	7e4c0db43a03ca11380a54f44a3cf1991e055b80
ToppCell	BL-critical-LOC-Lymphoid-Treg\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.22e-05	200	113	6	04d95a9102248e98eed069840ea6d3d23a243fd5
ToppCell	COVID-19-COVID-19_Severe-Myeloid-Neutrophil\|COVID-19_Severe / Disease, condition lineage and cell class	CEBPD ALPK1 SCARF1 FCGR2A TLR2 DHRS9	1.22e-05	200	113	6	fec2660c9a9977b3b3a2eaed063b9049c0b07ff2
ToppCell	COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.22e-05	200	113	6	f6b5320cdfe640a71e6e2df26f30d42e64b1c921
ToppCell	COVID-19-Lymphoid-Proliferating_CD8_T_cells\|Lymphoid / Condition, Lineage and Cell class	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.22e-05	200	113	6	4556bb626ca1a00a6db13d2adb35acb8ba848f9c
ToppCell	356C-Myeloid-Dendritic-cDC_proliferating_1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.22e-05	200	113	6	5b014c658eecc5e73679e5feb7a2aaa3d297001d
ToppCell	COVID_vent-Lymphocytic-Proliferative_Lymphocyte\|COVID_vent / Disease condition, Lineage, Cell class and subclass	ATAD5 BRCA2 NCAPD2 SGO2 POLQ HELLS	1.22e-05	200	113	6	9775ca7dedb76fcbb74f80f86b33c94e394c320a
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-7\|TCGA-Brain / Sample_Type by Project: Shred V9	BRCA2 NCAPD2 SGO2 POLQ HELLS	2.53e-05	136	113	5	d94f0fbeb7b80d4cf0687d1924ebf8f9dd07358c
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D175\|Adult / Lineage, Cell type, age group and donor	CEBPD DNAH14 FAT1 STS UNC13C	4.05e-05	150	113	5	b0b6ba3686d3eb8a9b249d30be14111de3b893be
ToppCell	PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_2\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ARMC3 ITGA2B CMTM5 CTTN VCL	5.67e-05	161	113	5	bfb79277889142133ce86492a808f3083a7547e8
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HSD17B7 PIWIL4 ADAMTSL3 ASXL3 ZNF432	5.67e-05	161	113	5	8aaca49b53a551395f4025ac4e535c7b0ce41a49
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related-ICC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HSD17B7 PIWIL4 ADAMTSL3 ASXL3 ZNF432	5.67e-05	161	113	5	deb10628d258fb813c293f81fb71be8e383dc82a
ToppCell	PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_2\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ARMC3 ITGA2B CMTM5 CTTN VCL	5.67e-05	161	113	5	d6f4b0e4e3b2a4e6232a6de3d67b210e24f8c89d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ATAD5 BRCA2 SGO2 POLQ HELLS	6.37e-05	165	113	5	88681101d7cf60b99b8ace5d8c0944323b937306
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ATAD5 BRCA2 NCAPD2 SGO2 POLQ	7.13e-05	169	113	5	b253a4a50c06d36228fcd5d856c57202cbac158f
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SPATA6L ARMC3 ZNF19 CFAP54 CPLANE1	7.13e-05	169	113	5	fba841664939c771881ba97f14ef1df6635c04ff
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ATAD5 ASXL3 NCAPD2 SGO2 HELLS	7.75e-05	172	113	5	2b6cd84c946b1e800caba452ae70145ea285fec1
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA2 NCAPD2 SGO2 POLQ HELLS	7.96e-05	173	113	5	a25459b8140b0dbcb73e3b4cc1407b679229f25c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ATAD5 BRCA2 SGO2 POLQ HELLS	8.18e-05	174	113	5	84da9faff088d05233183b425385beb054c92d1b
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ATAD5 BRCA2 NCAPD2 SGO2 POLQ	8.18e-05	174	113	5	c26eac176e9b0cba385630fdc60e0314a4e4caac
ToppCell	PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PWP2 NCAPD2 NAV2 SGO2 HELLS	8.18e-05	174	113	5	72df66319f6efbd88ecf439013d97409fbf3cb52
ToppCell	PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PWP2 NCAPD2 NAV2 SGO2 HELLS	8.18e-05	174	113	5	c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PLEKHG4B BRCA2 TLR2 SGO2 POLQ	8.40e-05	175	113	5	f7d191cde68de8f3457fa62b1df53b6d0dbe5001
ToppCell	367C-Lymphocytic-NK_cells-Proliferating_NK_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ATAD5 SCARF1 BRCA2 POLQ TRAV25	8.40e-05	175	113	5	0b1aaa028ba844d4bcb4509fdab8bee648373935
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA2 NCAPD2 SGO2 UNC13C POLQ	8.40e-05	175	113	5	876cea684faf42ff3eb4623ad6d7a1fb1276ee02
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO9A DAPK1 PLEKHG4B NAV2 FGD3	8.87e-05	177	113	5	9af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LRCH2 MYO1B GRID1 ADAMTSL3 LZTS1	9.10e-05	178	113	5	185b44700f06ec58b3c09c80520502166c965fd6
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ARMC3 ZNF19 CFAP54 C6orf118 C8B	9.10e-05	178	113	5	de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1B FREM1 RGS16 ASXL3 UNC13C	9.35e-05	179	113	5	d3438fed0d85d5ed5afa8ff820c45143d77b6c0d
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARMC3 RANBP9 C6orf118 SGO2 HELLS	9.60e-05	180	113	5	0c146e80d55d18b6988dd21b1da635801bd3140c
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARMC3 RANBP9 C6orf118 SGO2 HELLS	9.60e-05	180	113	5	e9af22beae2f3c7fe213b4e19df84abfd2453433
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARMC3 RANBP9 C6orf118 SGO2 HELLS	9.60e-05	180	113	5	11455ba704ac73f69b474845136cfecec6a88349
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Positive	TNIK DAPK1 ITGA2B C8B CTTN	1.03e-04	131	104	5	C4704862
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Negative	TNIK DAPK1 ITGA2B C8B CTTN	1.03e-04	131	104	5	C4552091
Disease	Juvenile arthritis	TNIK DAPK1 ITGA2B C8B CTTN	1.03e-04	131	104	5	C3495559
Disease	Juvenile psoriatic arthritis	TNIK DAPK1 ITGA2B C8B CTTN	1.03e-04	131	104	5	C3714758
Disease	Juvenile-Onset Still Disease	TNIK DAPK1 ITGA2B C8B CTTN	1.19e-04	135	104	5	C0087031
Disease	Thrombocytopenia	ITGA2B PTPRJ FCGR2A	1.45e-04	29	104	3	C0040034
Disease	attention deficit hyperactivity disorder, parental emotion expression measurmement	PIWIL4 MTUS2	5.44e-04	10	104	2	EFO_0003888, EFO_0008342
Disease	diffuse scleroderma (is_implicated_in)	FCGR2A TLR2	6.63e-04	11	104	2	DOID:1580 (is_implicated_in)
Disease	ovarian carcinoma	TNIK ATAD5 DAPK1 ASXL3 MTUS2 NUP153	9.83e-04	321	104	6	EFO_0001075
Disease	quinate measurement	GRID1 LEPR	1.25e-03	15	104	2	EFO_0021167
Disease	renal fibrosis (implicated_via_orthology)	LEPR TLR2	1.62e-03	17	104	2	DOID:0050855 (implicated_via_orthology)
Disease	Antibody Deficiency Syndrome	LEPR C8B	1.62e-03	17	104	2	C0003257
Disease	body weight	ZCCHC12 ATAD5 VPS13C GRID1 CHD8 ADAMTSL3 DNAH14 PTPRJ ASXL3 CHFR CDYL CPNE4	1.63e-03	1261	104	12	EFO_0004338
Disease	MYELODYSPLASTIC SYNDROME	DAPK1 BRCA2 TLR2	1.73e-03	67	104	3	C3463824
Disease	Phenyllactate (PLA) measurement	DAPK1 CNOT1	2.02e-03	19	104	2	EFO_0021662
Disease	lysophosphatidylcholine 20:5 measurement	DNASE2B CPNE4	2.02e-03	19	104	2	EFO_0010364
Disease	wellbeing measurement, alcohol consumption measurement	MMP27 PABPC4L CPNE4	2.30e-03	74	104	3	EFO_0007869, EFO_0007878
Disease	mucocutaneous lymph node syndrome	RPN2 PTPRJ FCGR2A	2.48e-03	76	104	3	EFO_0004246
Disease	epilepsy (implicated_via_orthology)	TNIK ANK2 UNC13C CDYL	2.69e-03	163	104	4	DOID:1826 (implicated_via_orthology)
Disease	Immunologic Deficiency Syndromes	LEPR C8B	2.97e-03	23	104	2	C0021051
Disease	response to anticonvulsant	ANK2 LEPR C6orf118	3.41e-03	85	104	3	GO_0036277

Protein segments in the cluster

Peptide	Gene	Start	Entry
SKNGNLQLHTDKGSF	ATAD5	456	Q96QE3
HKIDFGNEFKNIFGT	DAPK1	166	P53355
FPSGNFAKHISKTNE	CCDC186	96	Q7Z3E2
FKDKTAGLTFHALSG	CFAP54	181	Q96N23
EKNFSFLSKGAGHTN	CHD8	1066	Q9HCK8
FLHGLFGSKTNFNSI	ABHD11	71	Q8NFV4
FFQNGKSQKFSHLDP	FCGR2A	156	P12318
KFGSQASQKASELGH	ARFGAP1	231	Q8N6T3
KNKKNSYHFSAGFGS	ARMC3	641	Q5W041
FSEGSRNKTHKQGST	ASXL3	916	Q9C0F0
TGKQELHSFVKAAFG	ALPK1	346	Q96QP1
KEFHQLQGFGKGSQA	MTUS2	76	Q5JR59
NLASGKGSTAHFSGF	RANBP9	496	Q96S59
KSGSSFVHQASFKFG	RANBP2	1446	P49792
SNSGDFAFGSKDKNF	RANBP2	2856	P49792
NRFHKNSDSGSSKTF	PUM3	21	Q15397
EAGAAHSLATKKGFT	ANK2	551	Q01484
QLFGGKFNFDQTHTK	CACNA1F	676	O60840
SGNEHGKFSIDSKTG	FAT1	3271	Q14517
SSFGFDINKEKAHSG	MMP27	471	Q9H306
NSVKVKFSGFEASHG	PTPRJ	831	Q12913
HFKGGQSGLNLSKNF	HELLS	751	Q9NRZ9
SFSDGGSKLGHSNKA	LZTS1	231	Q9Y250
HFNLLSSKGADKSSN	HTATIP2	126	Q9BUP3
AGQGSHSRQKKTFFL	GALNT10	51	Q86SR1
TFGGFQVTSKGALHK	HLCS	251	P50747
SSHSDGAQYSKRFKG	DCAF8L2	451	P0C7V8
NSFNKGKHGFSDNQK	PCNP	146	Q8WW12
FESGHKSNVFQAKFL	DCAF8	231	Q5TAQ9
KGHSAFLSGDDLKFA	FREM1	36	Q5H8C1
CGKSFISSGELNKHF	MYNN	476	Q9NPC7
KFNSSGTHFSNLSKT	LEPR	71	P48357
HKQNSETFKAFGGAF	FGD3	471	Q5JSP0
ANKENVFHGTKDTSG	CHFR	136	Q96EP1
NSSFSKVKNVHTDGF	BCLAF3	586	A2AJT9
SAQGQKFLHFAKSDS	DNASE2B	231	Q8WZ79
AASHGFGKTSGNSFK	BRCA2	261	P51587
GKAHGGNNNKYSTFS	C1QL2	266	Q7Z5L3
GKDHESKNSQLFAAS	CDYL	156	Q9Y232
LFADLFNSNHKAGGA	CEBPD	81	P49716
NKDFSGAAKSHFECG	CPLANE1	911	Q9H799
NEFTSGDGKKAHQDF	UPB1	296	Q9UBR1
SAGAFSKSEGQHENF	POLQ	1271	O75417
NGKHDFIGEFTSTFK	CPNE4	236	Q96A23
LLKNDFTGSKAAAGH	C6orf118	231	Q5T5N4
KSNFSLEDFQHSKGK	HSD17B7	176	P56937
LFSFGFKSANSLSGK	DNAH14	1276	Q0VDD8
ADGKSLKLHSFAGVF	GRID1	821	Q9ULK0
SFDAGKIAHTKSFGV	CCDC168	4471	Q8NDH2
FGNLAARTFDKKGFH	DHRS9	41	Q9BPW9
HSFGSNAVNKSFAKS	C8B	36	P07358
HAFGGNKASYGKKTQ	DHX8	541	Q14562
NAHIGSFVSFFKGKE	LRCH2	421	Q5VUJ6
SGKSKGFGFVSFDSH	PABPC4L	226	P0CB38
FKTQGSHGSQGADFS	PCARE	116	A6NGG8
TSGTVKFDGNKQHFF	NXT2	96	Q9NPJ8
SSSSKQGDADFHGKA	SPATA6L	296	Q8N4H0
AGAGKTKRAFDFSAH	PUS3	46	Q9BZE2
AHAATSGKQSNFSRK	SPATS2L	376	Q9NUQ6
SSGKIFKDFHEGAIN	SYNJ2	761	O15056
LKESGKQHGFASFSD	SARAF	146	Q96BY9
TSKFGHGRFQTAQEK	RPL3L	371	Q92901
KADVKGHGATNDLTF	ITIH3	516	Q06033
LFSAGKGFTDHQTQK	SLITRK3	936	O94933
NSFGFKKQSGSAAGL	NAV2	1141	Q8IVL1
SHSELSNKAKAFDGA	PIWIL4	146	Q7Z3Z4
TALFSSKDFAGKSQH	STS	291	P08842
LSQSSGKFHQESKFD	SGO2	506	Q562F6
GKFHQESKFDKGQNS	SGO2	511	Q562F6
NGSQFGFSLDFHKDS	ITGA2B	46	P08514
HFGSFQKGQAEAKVK	SCARF1	711	Q14162
AALAKNFFNELSHKG	NCAPD2	1146	Q15021
QGFAVDKAFLTSHKG	CMTM5	21	Q96DZ9
GKSSGKDFHQTQFLI	CNOT1	61	A5YKK6
GKSFNQFSSLNIHKI	ZNF107	726	Q9UII5
GKSFTNFSQLSAHAK	ZNF562	266	Q6V9R5
EKKRSGHSDSNGFAG	TNIK	911	Q9UKE5
NKTQTFDKQGFHAGT	UBAP2	1021	Q5T6F2
FGGFKTKGINQKASH	USPL1	796	Q5W0Q7
SGKAFSQSSGFRGNK	ZNF705A	261	Q6ZN79
SKYEKAFGTSSQLGH	ZNF19	416	P17023
KKDGFQQTSEHALFS	UNC13C	1716	Q8NB66
KAKGTFIADSHQNFA	RPN2	401	P04844
EKHASQKDYSSGFGG	CTTN	146	Q14247
QTLGGDSTFFKSFNK	SYCP1	26	Q15431
ALLSSHGNAFFKDKQ	PLEKHG4B	906	Q96PX9
GDFNNLTAAAFHKKS	PWP2	286	Q15269
ANFENHSGKLGATAE	VCL	631	P18206
GKAFGNFSTLTKHKV	ZNF728	346	P0DKX0
NGSKGKFNLEDTSHR	ZDBF2	1661	Q9HCK1
KGFTADLNKGETSFH	TRAV16	76	A0A0A6YYK6
GECGKSFSHSSNLKN	ZNF211	456	Q13398
ALQKAAEKGTHSGEF	VPS13C	121	Q709C8
SSKNGVAAFHAFLKT	RGS16	71	O15492
SGKAFSQSSGFRGNK	ZNF705EP	261	A8MWA4
SKNDNFKFGLSSGLS	NUP153	976	P49790
SGKAFSQSSGFRGNK	ZNF705G	261	A8MUZ8
SGKAFSQSSGFRGNK	ZNF705B	261	P0CI00
SGKAFSQSSGFRGNK	ZNF705D	261	P0CH99
GKGFSQNSDLSIHQK	ZNF41	431	P51814
GKSSSKYDSFSNHQG	ZNF552	246	Q9H707
HGKFFNTLQAQGEKA	ZCCHC18	131	P0CG32
TKFSGDGKSFLHGNY	ZNF432	156	O94892
FQFGEAKKNSSLHIT	TRAV25	81	A0A0B4J276
SGKAFNGSSLLKKHQ	ZNF701	286	Q9NV72
SFHTLKTLEAGGNNF	TLR2	521	O60603
FFTARKGSKQDAAGH	ZNF106	1856	Q9H2Y7
HGKFFNTLQAQGEKA	ZCCHC12	131	Q6PEW1
GKVFNDSGNLSNHKR	ZNF836	616	Q6ZNA1
ECGKAFSGKSNLTNH	ZNF311	531	Q5JNZ3
SKTLQGSKGEHSFNS	ADAMTSL3	271	P82987
NIKSSGDKGNFSVHS	KRT74	6	Q7RTS7
SQNDGFFAVHLKEGS	MYO1B	1041	O43795
KTAHNNNSSRFGKFI	MYO9A	286	B2RTY4
KTAHNNNSSRFGKFI	MYO9B	286	Q13459